Total Holdings
256
As of Oct 4, 2026
Invesco Nasdaq Biotechnology ETF
IBBQNASDAQInvescoEquity
$33.75Today:- (-)1Y +34.06%
As of Oct 16, 2026 close
- Assets (AUM)
- $105.68M
- Expense ratio
- 0.19%
- Dividend yield
- 1.13%
- Holdings
- 256
- 52-week range
- $25.55$36.84
- Volume (live)
- -
- Avg. volume (3M)
- 42.13K
IBBQ ETF Holdings: Invesco Nasdaq Biotechnology ETF
Every listed position with its portfolio weight, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Top 10 Holdings
47.2%
Share of fund assets
Assets (AUM)
$105.68M
Total fund assets
Expense Ratio
0.19%
Annual management fee
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 of 256 IBBQ Holdings by Portfolio Weight
Holdings as of Oct 4, 2026. Ticker, name, asset type and portfolio weight for each position. Fund disclosures available to us list the largest 50 positions.
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Amgen Inc | Stock | 8.67% |
| 2 |  | Vertex Pharmaceuticals Incorporated | Stock | 8.14% |
| 3 |  | Gilead Sciences, Inc. | Stock | 8.11% |
| 4 |  | Regeneron Pharmaceuticals, Inc | Stock | 5.48% |
| 5 |  | Moderna, Inc. | Stock | 5.09% |
| 6 |  | Revolution Medicines, Inc. | Stock | 2.97% |
| 7 |  | Illumina, Inc. | Stock | 2.77% |
| 8 |  | Biogen Inc. | Stock | 2.18% |
| 9 |  | Alnylam Pharmaceuticals, Inc. | Stock | 1.97% |
| 10 |  | argenx NV ADR | Stock | 1.83% |
| 11 |  | Insmed Incorporated | Stock | 1.74% |
| 12 |  | Roivant Sciences Ltd. | Stock | 1.73% |
| 13 |  | Royalty Pharma plc | Stock | 1.73% |
| 14 |  | Incyte Corporation | Stock | 1.63% |
| 15 |  | Guardant Health, Inc. | Stock | 1.60% |
| 16 |  | United Therapeutics Corporation | Stock | 1.56% |
| 17 |  | Viatris Inc. | Stock | 1.36% |
| 18 |  | Medpace Holdings, Inc | Stock | 1.13% |
| 19 |  | BridgeBio Pharma, Inc | Stock | 1.04% |
| 20 |  | Jazz Pharmaceuticals plc | Stock | 1.03% |
| 21 |  | Ascendis Pharma AS | Stock | 1.01% |
| 22 |  | Neurocrine Biosciences, Inc | Stock | 0.99% |
| 23 |  | Exelixis, Inc. | Stock | 0.97% |
| 24 |  | Summit Therapeutics Inc. | Stock | 0.90% |
| 25 |  | Tempus AI, Inc. | Stock | 0.90% |
| 26 |  | BioMarin Pharmaceutical Inc | Stock | 0.84% |
| 27 |  | BioNTech SE | Stock | 0.83% |
| 28 |  | Halozyme Therapeutics, Inc | Stock | 0.81% |
| 29 |  | Arrowhead Pharmaceuticals, Inc | Stock | 0.79% |
| 30 | BGNE | BeiGene, Ltd | Stock | 0.79% |
| 31 |  | Madrigal Pharmaceuticals, Inc | Stock | 0.77% |
| 32 |  | Axsome Therapeutics, Inc | Stock | 0.69% |
| 33 |  | Sanofi | Stock | 0.67% |
| 34 |  | Cytokinetics, Incorporated | Stock | 0.67% |
| 35 |  | Praxis Precision Medicines, Inc | Stock | 0.65% |
| 36 |  | Kymera Therapeutics, Inc | Stock | 0.64% |
| 37 |  | Krystal Biotech, Inc | Stock | 0.64% |
| 38 |  | Ionis Pharmaceuticals, Inc | Stock | 0.62% |
| 39 |  | Protagonist Therapeutics Inc | Stock | 0.62% |
| 40 |  | Spyre Therapeutics Inc. | Stock | 0.60% |
| 41 |  | Immunovant Inc | Stock | 0.58% |
| 42 |  | Crinetics Pharmaceuticals Inc | Stock | 0.57% |
| 43 |  | Vaxcyte, Inc | Stock | 0.57% |
| 44 |  | Twist Bioscience Corporation | Stock | 0.54% |
| 45 |  | Apogee Therapeutics, Inc. Common Stock | Stock | 0.54% |
| 46 | NK | NantKwest Inc | Stock | 0.53% |
| 47 |  | Alkermes plc | Stock | 0.51% |
| 48 |  | Rhythm Pharmaceuticals, Inc | Stock | 0.48% |
| 49 |  | 10x Genomics, Inc | Stock | 0.48% |
| 50 |  | Caris Life Sciences, Inc. Common Stock | Stock | 0.45% |
Source: Fund holdings disclosures. Data as of Oct 4, 2026. Data sources and methodology
Frequently Asked Questions About Invesco Nasdaq Biotechnology ETF Holdings
What are the top holdings in IBBQ?
As of Oct 4, 2026, Invesco Nasdaq Biotechnology ETF (IBBQ) holds 256 securities. The largest are Amgen Inc (8.67%), Vertex Pharmaceuticals Incorporated (8.14%), Gilead Sciences, Inc. (8.11%). The holdings table lists each position by portfolio weight with its ticker, name and asset type.
How concentrated is IBBQ's portfolio?
As of Oct 4, 2026, the 10 largest positions make up 47.2% of IBBQ's assets. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly.
What is IBBQ's sector allocation?
The Sector Allocation chart shows how IBBQ distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does IBBQ invest in?
IBBQ's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is IBBQ ETF?
IBBQ's diversification can be assessed by reviewing its 256 holdings (as of Oct 4, 2026), sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.